Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: A retrospective database study

Clinical Therapeutics

Volumn 29, Issue 2, 2007, Pages 316-325

  Yurgin, Nicole ^a   Secnik, Kristina ^a   Lage, Maureen J ^b  

^a ELI LILLY AND COMPANY   (United States)

^b HealthMetrics Outcomes Research LLC   (United States)

Author keywords

antidiabetic prescriptions; Germany; glycemic control; glycosylated hemoglobin; HbA1c; type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GERMANY; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCRIPTION;

AGE FACTORS; AGED; BLOOD GLUCOSE; COMORBIDITY; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; SEX FACTORS; SULFONYLUREA COMPOUNDS;

EID: 34247487882     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.02.012     Document Type: Article

References (25)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. Jonsson B., and CODE-2 Advisory Board. Revealing the cost of type II diabetes in Europe. Diabetologia 45 (2002) S5-S12
3. Michaelis D., Jutzi E., and Vogt L. Epidemiology of insulin-treated diabetes mellitus in the East-German population: Differences in long-term trends between incidence and prevalencerates. Diabete Metab. 19 (1993) 110-115
4. Thefeld W. Prevalence of diabetes mellitus in the adult German population [in German]. Gesundheitswesen 61 (1999) S85-S89
5. Liebl A., Neiss A., Spannheimer A., et al. Complications; comorbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany-results from the CODE-2 study. Exp Clin Endocrinol Diabetes 110 (2002) 10-16
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
7. [published correction appears in Lancet. 1999;354: 602]. The UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or in-sulin compared with conventional treatment and risk of complications in patients withtype 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
8. [published correction appears in Lancet. 1998;352:1558]. The UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 (1998) 854-865
9. Available at:. National Institute for Clinical Excellence. Management of type 2 diabetes: Management of blood glucose. Accessed October 12; 2006 (September 2002). http://www.nice.org.uk/pdf/NICE_INHERITEG_guidelines.pdf
10. European Diabetes Policy Group 1999. A desktop guide to type 2 diabetes mellitus. Diabet Med 16 (1999) 716-730
11. Liebl A., Mata M., Eschwege E., and CODE-2 Advisory Board. Evaluation of risk factors for development of complications in type II diabetes in Europe. Diabetologia 45 (2002) S23-S28
12. Dietlein G., and Schroder-Bernhardi D. Use of the Mediplus patient database in healthcare research. Int J Clin Pharmacol Ther 40 (2002) 130-133
13. Sittl R., Nuijten M., and Nautrup B.P. Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: A retrospective data analysis in Germany. Clin Ther 28 (2006) 1144-1154
14. Available at:. European Agency for the Evaluation of Medicinal Products. Accessed. International Conference on HarmonisationWorld Health Organization. ICH Topic E6 (2006-October 11, 2006). http://www.emea.europa.eu
15. Saudek C.D., Kalyani R.R., and Derr R.L. Assessment of glycemia in diabetes mellitus: Hemoglobin A1c. J Asso Physicians India 53 (2005) 299-305
16. 1c? The ABCs of hemoglobin A1c testing... The best test of blood sugar control for people with diabetes (2006-October 11, 2006). http://www.diabetestoolbox.com/HbA1c.asp
17. Ford E.S., Williamson D.F., and Liu S. Weight change and diabetes incidence: Findings Rom a national cohort of US adults. Am J Epidemiol 146 (1997) 214-222
18. Klein R., Klein B.E., Lee K.E., et al. The incidence of hyperten-sion in insulin-dependent diabetes. Arch Intern Med 156 (1996) 622-627
19. Egede L.E., Zheng D., and Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25 (2002) 464-470
20. Pouwe F., Beekman A.T., Nijpels G., et al. Rates and risks for comorbid depression in patients with type 2 diabetes mellitus: Results from a community-based study. Diabetologia 46 (2003) 892-898
21. Available at:. Federation of European Nurses in Diabetes and International Diabetes Federation, European Region. Diabetes. The policy puzzle: Towards benchmarking in the EU 25. Accessed (October 12, 2006). europe/ DiabetesReport2005.pdf
22. American Diabetes Association Clinical Practice Recommendations 2001. Diabetes Care 24 Suppl 1 (2001) S1-S133
23. Calabrese A.T., Coley K.C., DaPos S.V., et al. Evaluation of prescribing practices: Risk or lactic acidosis with metformin therapy. Arch Intern Med 162 (2002) 434-437
24. [published correction appears in JAMA. 1999;281:1989]. Hayward R.A., Manning W.G., Kaplin S.H., et al. Starting insulin therapy in patients with type 2 diabetes: Effectiveness; complications; and resource utilization. JAMA 278 (1997) 1663-1669
25. Benoit S.R., Fleming R., Philis-Tsimikas A., and Ji M. Predictors of glycemic control among patients with type 2 diabetes: A longitudinal study. BMC Public Health 5 (2005) 36